Transmission of SARS-CoV-2 in northern Ghana: insights from whole-genome sequencing.
Journal
Archives of virology
ISSN: 1432-8798
Titre abrégé: Arch Virol
Pays: Austria
ID NLM: 7506870
Informations de publication
Date de publication:
May 2021
May 2021
Historique:
received:
11
10
2020
accepted:
21
12
2020
pubmed:
17
3
2021
medline:
16
4
2021
entrez:
16
3
2021
Statut:
ppublish
Résumé
Following the detection of the first imported case of COVID-19 in the northern sector of Ghana, we molecularly characterized and phylogenetically analysed sequences, including three complete genome sequences, of severe acute respiratory syndrome coronavirus 2 obtained from nine patients in Ghana. We performed high-throughput sequencing on nine samples that were found to have a high concentration of viral RNA. We also assessed the potential impact that long-distance transport of samples to testing centres may have on sequencing results. Here, two samples that were similar in terms of viral RNA concentration but were transported from sites that are over 400 km apart were analyzed. All sequences were compared to previous sequences from Ghana and representative sequences from regions where our patients had previously travelled. Three complete genome sequences and another nearly complete genome sequence with 95.6% coverage were obtained. Sequences with coverage in excess of 80% were found to belong to three lineages, namely A, B.1 and B.2. Our sequences clustered in two different clades, with the majority falling within a clade composed of sequences from sub-Saharan Africa. Less RNA fragmentation was seen in sample KATH23, which was collected 9 km from the testing site, than in sample TTH6, which was collected and transported over a distance of 400 km to the testing site. The clustering of several sequences from sub-Saharan Africa suggests regional circulation of the viruses in the subregion. Importantly, there may be a need to decentralize testing sites and build more capacity across Africa to boost the sequencing output of the subregion.
Identifiants
pubmed: 33723631
doi: 10.1007/s00705-021-04986-3
pii: 10.1007/s00705-021-04986-3
pmc: PMC7959303
doi:
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
1385-1393Subventions
Organisme : Medical Research Council
ID : MR/J01477X/1
Pays : United Kingdom
Références
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Lancet. 2020 Feb 22;395(10224):565-574
pubmed: 32007145
Pan Afr Med J. 2020 Jun 09;36:80
pubmed: 32774639
New Microbes New Infect. 2020 Jul;36:100717
pubmed: 32566234
Nature. 2020 Apr;580(7805):565
pubmed: 32346145
Lancet. 2003 Oct 25;362(9393):1353-8
pubmed: 14585636
Infect Genet Evol. 2020 Apr;79:104212
pubmed: 32004758
Lancet. 2020 Mar 14;395(10227):871-877
pubmed: 32087820
J Mol Diagn. 2017 Mar;19(2):303-312
pubmed: 28041870
Chaos Solitons Fractals. 2020 Nov;140:110103
pubmed: 32834629
Pan Afr Med J. 2020 Apr 14;35(Suppl 2):4
pubmed: 32528615
Emerg Infect Dis. 2013 Jun;19(6):989-91
pubmed: 23739658
Emerg Infect Dis. 2017 Dec;23(13):
pubmed: 29155668
Appl Transl Genom. 2016 Mar 10;9:15-9
pubmed: 27354935
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Cell. 2020 Aug 20;182(4):812-827.e19
pubmed: 32697968
Math Biosci. 2020 Oct;328:108441
pubmed: 32763338
Cell Res. 2013 Aug;23(8):986-93
pubmed: 23835475
Acta Biomed. 2020 Mar 19;91(1):157-160
pubmed: 32191675
AAS Open Res. 2020 Apr 17;3:4
pubmed: 32399515
Cell Res. 2020 Aug;30(8):670-677
pubmed: 32636454
Nat Microbiol. 2020 Nov;5(11):1403-1407
pubmed: 32669681
Lancet Glob Health. 2020 Jul;8(7):e884-e885
pubmed: 32416768